KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precigen (PGEN) Current Deferred Revenue (2016 - 2025)

Precigen (PGEN) has disclosed Current Deferred Revenue for 13 consecutive years, with $575000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Current Deferred Revenue rose 41.28% to $575000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $575000.0, a 41.28% increase, with the full-year FY2024 number at $2.5 million, up 8.42% from a year prior.
  • Current Deferred Revenue was $575000.0 for Q3 2025 at Precigen, down from $2.2 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $24.5 million in Q4 2021 to a low of $15000.0 in Q1 2023.
  • A 5-year average of $2.9 million and a median of $2.2 million in 2024 define the central range for Current Deferred Revenue.
  • Peak YoY movement for Current Deferred Revenue: plummeted 99.9% in 2022, then surged 15200.0% in 2024.
  • Precigen's Current Deferred Revenue stood at $24.5 million in 2021, then tumbled by 99.9% to $25000.0 in 2022, then skyrocketed by 9208.0% to $2.3 million in 2023, then increased by 8.42% to $2.5 million in 2024, then crashed by 77.21% to $575000.0 in 2025.
  • Per Business Quant, the three most recent readings for PGEN's Current Deferred Revenue are $575000.0 (Q3 2025), $2.2 million (Q2 2025), and $2.4 million (Q1 2025).